Reevaluation of the indications for radical pancreatectomy to treat pancreatic carcinoma: Is portal vein infiltration a contraindication?

被引:36
作者
Kawada, M [1 ]
Kondo, S [1 ]
Okushiba, S [1 ]
Morikawa, T [1 ]
Katoh, H [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Div Canc Med, Kita Ku, Sapporo, Hokkaido 06085638, Japan
关键词
pancreatic carcinoma; portal vein infiltration; portal vein resection; survival;
D O I
10.1007/s005950200108
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose. Portal vein resection (PVR) has become more widely performed owing to improvements in the perioperative mortality rate. The present study was performed to determine whether portal vein infiltration is a contraindication against radical pancreatectomy for patients with pancreatic carcinoma. Methods. Between 1990 and 1997, a total of 66 patients with invasive ductal carcinoma of the pancreas underwent surgical resection at the Department of Surgery 11, Hokkaido University Hospital. After the exclusion of those who underwent distal pancreatectomy, the remaining 43 patients were divided into a PVR(+) group (n = 28) and a PVR(-) group (n = 15). The clinicopathological characteristics, morbidity, and mortality were statistically compared between the two groups. Results. The overall survival rate of the patients who required PVR was not significantly different from that of those who underwent pancreatic resection without PVR. Conclusion. These findings suggest that combined PVR should not be a contraindication to radical pancreatectomy for pancreatic carcinoma with positive vascular invasion.
引用
收藏
页码:598 / 601
页数:4
相关论文
共 19 条
[1]  
Fernandez-del Castillo C, 1995, ARCH SURG-CHICAGO, V130, P295
[2]  
FORTNER JG, 1973, SURGERY, V73, P307
[3]   Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric portal vein confluence [J].
Fuhrman, GM ;
Leach, SD ;
Staley, CA ;
Cusack, JC ;
Charnsangavej, C ;
Cleary, KR ;
ElNaggar, AK ;
Fenoglio, CJ ;
Lee, JE ;
Evans, DB .
ANNALS OF SURGERY, 1996, 223 (02) :154-162
[4]  
Harrison LE, 1996, ANN SURG, V224, P342, DOI 10.1097/00000658-199609000-00010
[5]   Pathology and biology of pancreatic ductal adenocarcinoma [J].
Hermanek, P .
LANGENBECKS ARCHIVES OF SURGERY, 1998, 383 (02) :116-120
[6]   PREOPERATIVE INDICATIONS FOR EXTENDED PANCREATECTOMY FOR LOCALLY ADVANCED PANCREAS CANCER INVOLVING THE PORTAL-VEIN [J].
ISHIKAWA, O ;
OHIGASHI, H ;
IMAOKA, S ;
FURUKAWA, H ;
SASAKI, Y ;
FUJITA, M ;
KURODA, C ;
IWANAGA, T .
ANNALS OF SURGERY, 1992, 215 (03) :231-236
[7]  
Klempnauer J, 1996, ONCOLOGY, V53, P47
[8]   Detection of matrix metalloproteinase activity in human pancreatic cancer [J].
Koshiba, T ;
Hosotani, R ;
Wada, M ;
Fujimoto, K ;
Lee, JU ;
Doi, R ;
Arii, S ;
Imamura, M .
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1997, 27 (04) :302-304
[9]   Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas [J].
Meyer, W ;
Jurowich, C ;
Reichel, M ;
Steinhäuser, B ;
Wünsch, PH ;
Gebhardt, C .
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 2000, 30 (07) :582-587
[10]   CLINICAL-SIGNIFICANCE OF PORTAL INVASION BY PANCREATIC HEAD CARCINOMA [J].
NAKAO, A ;
HARADA, A ;
NONAMI, T ;
KANEKO, T ;
INOUE, S ;
TAKAGI, H .
SURGERY, 1995, 117 (01) :50-55